Welcome to our dedicated page for Cerence SEC filings (Ticker: CRNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cerence Inc. SEC filings document formal disclosures for a public software company focused on conversational AI-powered user experiences. Recent 8-K filings include earnings releases and investor presentations with GAAP and non-GAAP financial measures, revenue and cash-flow disclosures, and commentary on software licensing, connected services and customer-program activity.
The filings also record shareholder meeting results, board elections, advisory compensation votes, auditor ratification, restructuring-related charges, executive compensation arrangements, and material intellectual-property matters, including patent litigation resolution and license agreements. These records frame Cerence's governance, operating costs, capital allocation and technology-rights disclosures.
Cerence Inc. reported that EVP and Chief Revenue Officer Christian Mentz received an award of 131,694 shares of common stock on January 9, 2026 at a price of $12.35 per share. The award is in the form of restricted stock units that vest in three equal parts on October 1, 2026, 2027, and 2028 under a Restricted Stock Unit Agreement. Following this grant, Mentz beneficially owns 293,474 shares of Cerence common stock in direct ownership.
Cerence Inc. executive Nils Schanz, EVP Product & Technology, reported receiving a grant of 87,796 shares of common stock on January 9, 2026. The filing describes this as a grant of restricted stock units under a Restricted Stock Unit Agreement at a reported price of $12.35 per share. According to the footnote, the shares vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Schanz beneficially owns 342,682 shares of Cerence common stock, held directly.
Cerence Inc. executive Jennifer Salinas, EVP Chief Admin Officer, received a sizable equity award. On January 9, 2026, she was granted 131,694 shares of common stock at a price of $12.35 per share, reported as an acquisition of non-derivative securities.
The grant is described as restricted stock units under a Restricted Stock Unit Agreement, with the shares vesting in three equal installments on October 1, 2026, October 1, 2027, and October 1, 2028. Following this grant, Salinas beneficially owns 720,027 shares of Cerence common stock directly.
Cerence Inc. CFO Antonio Rodriquez reported an equity award on a Form 4. On January 9, 2026, he was granted 131,694 shares of Common Stock, reflecting restricted stock units with a reported value of $12.35 per share.
The footnote explains this is a grant of Restricted Stock Units under a Restricted Stock Unit Agreement. The RSUs vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Rodriquez beneficially owned 575,246 shares of Cerence common stock, held directly.
Cerence Inc. (CRNC) reported an equity award to its Chief Executive Officer and director on a Form 4. On 11/21/2025, the executive acquired 552,766 shares of common stock at a price of $10.35 per share, classified as an acquisition transaction. Following this grant, the executive beneficially owns 1,458,753 shares of Cerence common stock in direct ownership.
The filing notes that this grant represents performance stock units (PSUs) achieved under the company’s FY25 plan, which are scheduled to vest in November 2027. This reflects a performance-based equity incentive aligning the CEO’s compensation with Cerence’s future results over the multi‑year performance period.
Cerence Inc. (CRNC) executive vice president and chief administrative officer reported acquiring 242,044 shares of common stock on 11/21/2025 at $10.35 per share. These shares reflect achieved performance stock units (PSUs) under the company’s fiscal 2025 plan that are scheduled to vest in November 2027.
Following this transaction, the officer beneficially owns 588,333 shares of Cerence common stock in direct ownership. The filing is made on Form 4 by a single reporting person and documents an equity-based compensation event rather than an open-market purchase.
Cerence Inc. (CRNC) reported an insider equity award for its CFO. On 11/21/2025, the chief financial officer acquired 166,821 shares of Cerence common stock at $10.35 per share, increasing beneficial ownership to 443,552 shares held directly. The filing explains that this grant represents achieved performance stock units under the FY25 plan, which are scheduled to vest in November 2027. This ties the executive’s compensation more closely to the company’s longer-term performance.
Cerence Inc. (CRNC) reported an equity award to its EVP and Chief Revenue Officer on a Form 4. On 11/21/2025, the executive acquired 49,905 shares of common stock at a price of $10.35 per share, reported as an acquired transaction. Following this award, the executive beneficially owns 161,780 shares of Cerence common stock in direct ownership.
The filing notes that this grant represents achieved performance stock units (PSUs) under the company’s FY25 plan, which are scheduled to vest in November 2027. This reflects part of the executive’s performance-based compensation structure tied to company goals over the fiscal 2025 period.
Cerence Inc. (CRNC) reported an equity transaction by its EVP, Product & Technology. On 11/21/2025, the executive acquired 49,905 shares of Cerence common stock at $10.35 per share. After this transaction, the executive beneficially owns 254,886 shares directly.
The company notes this grant represents performance stock units (PSUs) achieved under the FY25 plan that are scheduled to vest in November 2027, tying the award to longer-term performance and retention.
Cerence Inc. (CRNC) reports fiscal 2025 revenue of $251.8 million, down 24% from $331.5 million a year earlier, reflecting softer demand and a shift in its business mix. The company posted a much smaller net loss of $18.7 million for the year ended September 30, 2025, compared with a net loss of $588.1 million in fiscal 2024.
Cerence remains a major player in automotive conversational and generative AI, with its technologies shipped in more than 525 million vehicles to date and an estimated 52% of all cars produced in fiscal 2025 including its solutions. As of September 30, 2025, it reported estimated five-year backlog of $1,169.2 million, including $165.2 million of remaining performance obligations and $1,004.0 million of variable backlog, up from $952.7 million a year earlier.
The company is restructuring through its 2024 and 2025 plans to reduce operating expenses and focus on profitable growth, while continuing to invest heavily in R&D and cloud-connected AI offerings for global automakers and tier-one suppliers.